Journal of Pharmaceutical Analysis (Sep 2024)
MEOX2 promotes glioma growth and temozolomide chemoresistance
- Tengfei Li,
- Kaijun Sun,
- Wanchun Yang,
- Meiling Zhang,
- Wentao Feng,
- Siliang Chen,
- Mingrong Zuo,
- Qiuyun Yuan,
- Yanhui Liu,
- Mina Chen
Affiliations
- Tengfei Li
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Kaijun Sun
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Wanchun Yang
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Meiling Zhang
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China
- Wentao Feng
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Siliang Chen
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Mingrong Zuo
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- Qiuyun Yuan
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China
- Yanhui Liu
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China; Corresponding author.
- Mina Chen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Corresponding author.
- Journal volume & issue
-
Vol. 14,
no. 9
p. 100912
